UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
CALL
Itaú Unibanco
ITUB
$90.5B
| $9.29M | ﹤0.01% |
1,394,944
| – | – |
|
2027
BlackRock TCP Capital
TCPC
$294M
| $9.27M | ﹤0.01% |
659,383
-29,133
| -4% | -$407K |
|
2028
BlackRock Enhanced Captial and Income Fund
CII
$1.01B
| $9.26M | ﹤0.01% |
536,841
+47,226
| +10% | +$781K |
|
|
GOOS
2029
Canada Goose Holdings
GOOS
$861M
| $9.24M | ﹤0.01% |
254,937
+78,126
| +44% | +$3.02M |
|
2030
PUT
Cheniere Energy
LNG
$53.4B
| $9.21M | ﹤0.01% |
150,800
| – | – |
|
|
SYNH
2031
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $9.21M | ﹤0.01% |
154,782
+66,296
| +75% | +$3.56M |
|
2032
Avnet
AVT
$7.97B
| $9.19M | ﹤0.01% |
216,495
+167,816
| +345% | +$6.91M |
|
|
XHR
2033
Xenia Hotels & Resorts
XHR
$1.89B
| $9.17M | ﹤0.01% |
424,184
+106,209
| +33% | +$2.24M |
|
2034
PUT
Waste Management
WM
$89.7B
| $9.16M | ﹤0.01% |
80,400
+400
| +0.5% | +$45.2K |
|
2035
Wynn Resorts
WYNN
$10.5B
| $9.13M | ﹤0.01% |
65,746
-29,092
| -31% | -$3.54M |
|
|
NUVA
2036
DELISTED
NuVasive, Inc.
NUVA
| $9.12M | ﹤0.01% |
117,910
+47,024
| +66% | +$3.32M |
|
2037
Murphy USA
MUSA
$10.7B
| $9.09M | ﹤0.01% |
77,678
+48,208
| +164% | +$5.2M |
|
|
IBMJ
2038
DELISTED
iShares iBonds Dec 2021 Term Muni Bond ETF
IBMJ
| $9.09M | ﹤0.01% |
352,744
-25,194
| -7% | -$650K |
|
2039
Americold
COLD
$4B
| $9.08M | ﹤0.01% |
259,091
+49,788
| +24% | +$1.83M |
|
2040
Bio-Techne
TECH
$11.2B
| $9.07M | ﹤0.01% |
165,340
+90,288
| +120% | +$4.74M |
|
2041
Tyler Technologies
TYL
$12.6B
| $9.07M | ﹤0.01% |
30,235
+4,731
| +19% | +$1.32M |
|
2042
Globe Life
GL
$14.3B
| $9.07M | ﹤0.01% |
86,167
+5,963
| +7% | +$594K |
|
|
ARQL
2043
CALL
DELISTED
Arqule Inc
ARQL
| $9.04M | ﹤0.01% |
+452,800
| New | +$5.25M |
|
2044
Sanmina
SANM
$10.7B
| $9.03M | ﹤0.01% |
263,857
+184,904
| +234% | +$5.92M |
|
2045
PUT
Thermo Fisher Scientific
TMO
$214B
| $9.03M | ﹤0.01% |
27,800
+12,500
| +82% | +$3.79M |
|
2046
Ciena
CIEN
$57.9B
| $9.03M | ﹤0.01% |
211,470
-59,332
| -22% | -$2.26M |
|
2047
BlackRock MuniYield Quality Fund
MQY
$811M
| $9.02M | ﹤0.01% |
599,359
+43,777
| +8% | +$656K |
|
2048
Gentherm
THRM
$1.28B
| $9.02M | ﹤0.01% |
203,101
-8,795
| -4% | -$375K |
|
2049
Xerox
XRX
$412M
| $9M | ﹤0.01% |
244,141
+49,522
| +25% | +$1.73M |
|
2050
CALL
Lumen
LUMN
$6.27B
| $9M | ﹤0.01% |
681,100
+166,400
| +32% | +$2.23M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.